Hover a dot or row, or tab through the dots · bars scaled to the largest round ($49.8M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-600992
First filed2026-10-13
Latest2026-10-13
Sought$57.5M
Sold$49.8M
Investors39
Exemptions506(b)
021-560322
First filed2025-10-09
Latest2025-10-09
Sought$20M
Sold$14.5M
Investors25
Exemptions506(b)
021-524353
First filed2024-09-18
Latest2025-01-08
Sought$10.5M
Sold$9.5M
Investors27
Exemptions506(b)
021-484042
First filed2023-06-13
Latest2023-06-13
Sought$2M
Sold$2M
Investors10
Exemptions506(b)
Who backs Curadel Surgical Innovations, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-10-13
Related persons
Name
Relationship
John V. Frangioni, M.D., Ph.D.
RelationshipExecutive Officer, Director
Garen Bohlin
RelationshipDirector
Marc V. Garnick, M.D.
RelationshipDirector
Sean Stalfort
RelationshipDirector
Walid Fakhry
RelationshipDirector
Facts
As its latest Form D states them
Industry
Biotechnology
State
Florida (FL)
Exemptions
Rule 506(b)
First filed
2023-06-13
Latest filing
2026-10-13
Who backs Curadel Surgical Innovations, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)